Drug Trial Radar · NCT03990649
Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)
Last checked: Nov 20, 2026Latest source record: Sep 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Jul 23, 2019
Primary completion
Jun 29, 2020
Study completion Oct 28, 2020
Sponsor
- Lead sponsor
- Millennium Pharmaceuticals, Inc.Takeda (TAK)
- Sponsor type
- Industry
- First posted
- Jun 19, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the effect of soticlestat (TAK-935) on calculated 24-hour average pain intensity by the numeric pain scale (NPS).
Conditions
- Complex Regional Pain Syndrome
Interventions
SoticlestatDrug
Soticlestat tablets
PlaceboDrug
Soticlestat matching placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean 24-Hour Pain Intensity as Assessed by NPS Score to the End of Part ATime frame: Baseline and Week 15
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
St Pancras Clinical Research
London, England, United Kingdom
Lancashire Teaching Hospitals NHS Foundation Trust
Preston, England, United Kingdom
University Hospital Southampton NHS Foundation Trust
Southampton, England, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.